hC Bioscience
David Moskowitz has worked in various roles since 2016. David began their career as an Intern at 8VC, before becoming a Consultant, Senior Associate, and finally a Principal. In 2021, they became a Board Director at hC Bioscience, Inc., Cartography Biosciences, and Appia Bio. David also became Co-founding investor and CEO of 8VC NewCo in 2021. In 2020, they became Co-founding investor and Board Director of Nuanced Health, and Board Observer of Unlearn.AI. In 2019, they were a Board Observer of Mantra Bio, BigHat Biosciences, and Sonoma Biotherapeutics.
David Moskowitz attended Stanford University from 2012 to 2017, where they obtained a Ph.D. in Biomedical Informatics. From 2014 to 2016, they also obtained an M.S. in Statistics from Stanford University. Prior to that, they attended Brown University from 2005 to 2009, where they obtained a Sc.B. in Computational Biology.
This person is not in the org chart
hC Bioscience
hC Bioscience, Inc Is an innovator and pioneer of protein editing using gene and context agnostic engineered tRNA Our First in Class approach for protein editing advances beyond genome editing to direct modification of the proteome.